First Tracks Biotherapeutics, Inc. (TRAX) Form 10-K Annual Reports
First Tracks Biotherapeutics, Inc. (TRAX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TRAX
CIK: 2091349
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerChristopher Finley
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001193125-26-422929 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-12 | 8-K | 0001193125-26-419761 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001477384-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 Filing | 0001715429-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-008997 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 Filing | 0002128786-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 Filing | 0001711462-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-15 | 4 Filing | 0001673528-26-000017 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352354 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000919574-26-005204 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001011438-26-000512 | View SEC Doc Filr Page |
| 424B3 | 2026-08-13 | — | 424B3 | 0001193125-26-349146 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-346931 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-346908 | View SEC Doc Filr Page |
| 3/A | 2026-08-07 | 2026-04-20 | 3/A Filing | 0001711462-26-000013 | View SEC Doc Filr Page |
| 3/A | 2026-08-07 | 2026-04-20 | 3/A Filing | 0002128786-26-000005 | View SEC Doc Filr Page |
| 3/A | 2026-08-07 | 2026-04-20 | 3/A Filing | 0001673528-26-000015 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-002002 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-02 | 4 Filing | 0002128786-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-02 | 4 Filing | 0001711462-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-02 | 4 Filing | 0001673528-26-000014 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-28 | — | SCHEDULE 13G Filing | 0002012383-26-002568 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-15 | 8-K | 0001193125-26-277504 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001707797-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001478916-26-000012 | View SEC Doc Filr Page |